The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Antioxidant Therapies for Alzheimer's Disease
Open accessAbstract
Alzheimer’s disease (AD) is the most common neurodegenerative disease featuring progressive impairments in memory, cognition, and behavior and ultimately leads to death. The histopathological changes of Alzheimer’s disease include neuronal and synaptic loss, formation of extracellular senile plaques and intracellular neurofibrillary tangles in brain. Multiple lines of evidence indicate that oxidative stress not only strongly participates in an early stage of Alzheimer’s disease prior to cytopathology, but plays an important role in inducing and activating multiple cell signaling pathways that contribute to the lesion formations of toxic substances and then promotes the development of Alzheimer’s disease. Many years of studies show that antioxidant therapies have enjoyed general success in preclinical studies. Therefore, this paper mainly focuses on the recent developments of common used antioxidant therapies for Alzheimer’s disease and thus provides indications for future potential antioxidant therapeutic strategies of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Cellular defenses against damage from reactive oxygen species
Yu, B. P. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,370
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Harman, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7124 · Cited by 1,915
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Goodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66051836.x · Cited by 830
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1×
“Protein oxidation and the oxidation of nuclear and mitochondrial DNA have been observed in both AD patients and in elderly patients without AD, but the oxidation of nuclear and mitochondrial DNA appears to be present in the parietal cortex [30], whereas protein oxidation appears to be more marked in AD patients in the…”
BackgroundAntioxidant defense systems: the role of carotenoids, tocopherols, and thiols
Di Mascio, P., Murphy, M., & Sies, H. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.194s · Cited by 776
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Bowry, V. W., & Stocker, R. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00067a019 · Cited by 713
Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713
Apolipoprotein E and Alzheimer disease.
Strittmatter, W. J., & Roses, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4725 · Cited by 699
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643
Involvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611
Evidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 599
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 519
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm821 · Cited by 515
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513
Age-Specific Incidence of Alzheimer's Disease in a Community Population
Hebert, L. E. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520410048025 · Cited by 475
Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons
Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., Szeto, H. H., Park, B., & Reddy, P. H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100564 · Cited by 469
Interaction among vitamin C, vitamin E, and beta-carotene
Niki, E., Noguchi, N., Tsuchihashi, H., & Gotoh, N. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1322s · Cited by 464
Alzheimer's disease: the two-hit hypothesis
Zhu, X., Raina, A. K., Perry, G., & Smith, M. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00707-0 · Cited by 426
Drug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 426
Mitochondria, free radicals, and neurodegeneration
Beal, M. F. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80100-0 · Cited by 424
Mechanism of antiinflammatory actions of curcumine and boswellic acids
Ammon, H. P. T., Safayhi, H., Mack, T., & Sabieraj, J. (1993) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(93)90005-p · Cited by 391
Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.
Pappolla, M. A., Omar, R. A., Kim, K. S., & Robakis, N. K. R. K. (1992) · PubMed · Cited by 365
Role of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain
Schipper, H. M., Cissé, S., & Stopa, E. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370609 · Cited by 356
Pratic�, D., Clark, C. M., Lee, V. M.-Y., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<809::aid-ana19>3.0.co;2-9 · Cited by 348
Wang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341
Self-citationEffects of antioxidant supplementation on the aging process.
Fusco, D., Colloca, G. A., Monaco, M. R. L., & Cesari, M. (2007) · PubMed · Cited by 339
Matsubara, E., Bryant‐Thomas, T., Pacheco Quinto, J., Henry, T. L., Poeggeler, B., Herbert, D., Cruz‐Sanchez, F., Chyan, Y., Smith, M. A., Perry, G., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01654.x · Cited by 332
Reddy, P. H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 326
Chang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., & Huang, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508254102 · Cited by 319
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318
Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease
Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K., Dolios, G., Wang, R., Hof, P. R., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3182fje · Cited by 316
Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis
Braun, J. S., Sublett, J. E., Freyer, D., Mitchell, T. J., Cleveland, J. L., Tuomanen, E. I., & Weber, J. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci12035 · Cited by 313
Thornalley, P. J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00157-9 · Cited by 308
Anti-Alzheimer and Antioxidant Activities of Coptidis Rhizoma Alkaloids
Jung, H. A., Min, B.-S., Yokozawa, T., Lee, J.-H., Kim, Y. S., & Choi, J. S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1433 · Cited by 307
ROTH, M., TOMLINSON, B. E., & BLESSED, G. (1966) · Nature · doi:10.1038/209109a0 · Cited by 298
Sung, S., Yao, Y., Uryu, K., Yang, H., Lee, V. M. ‐., Trojanowski, J. Q., & Praticò, D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0961fje · Cited by 298
Mitochondria: A therapeutic target in neurodegeneration
Moreira, P. I., Zhu, X., Wang, X., Lee, H.-G., Nunomura, A., Petersen, R. B., Perry, G., & Smith, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 285
Self-citationAge-related changes in glutathione and glutathione-related enzymes in rat brain
Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 277
Can oxidative damage be treated nutritionally?
BERGER, M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.10.003 · Cited by 276
Dietary Antioxidants and Long-term Risk of Dementia
Devore, E. E., Grodstein, F., van Rooij, F. J. A., Hofman, A., Stampfer, M. J., Witteman, J. C. M., & Breteler, M. M. B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.144 · Cited by 276
Gonzalez-Zulueta, M., Ensz, L. M., Mukhina, G., Lebovitz, R. M., Zwacka, R. M., Engelhardt, J. F., Oberley, L. W., Dawson, V. L., & Dawson, T. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02040.1998 · Cited by 265
Vitamin E and Alzheimer disease: the basis for additional clinical trials
Grundman, M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.630s · Cited by 264
James, A. M., Sharpley, M. S., Manas, A.-R. B., Frerman, F. E., Hirst, J., Smith, R. A. J., & Murphy, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611463200 · Cited by 262
Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.-Q., Bien-Ly, N., Puoliväli, J., Scearce-Levie, K., Masliah, E., & Mucke, L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0482-06.2006 · Cited by 254
Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease
Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 239
Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges
Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15314 · Cited by 237
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
Foy, C. J. (1999) · QJM · doi:10.1093/qjmed/92.1.39 · Cited by 235
Stackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230
Amyloid-beta precursor protein processing in neurodegeneration
Wilquet, V., & Strooper, B. D. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.08.001 · Cited by 229
Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
Kontush, A., Finckh, B., Karten, B., Kohlschütter, A., & Beisiegel, U. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39128-8 · Cited by 216
Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease
Thomas, T. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00100-7 · Cited by 201
Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice
Lu, P., Mamiya, T., Lu, L., Mouri, A., Zou, L., Nagai, T., Hiramatsu, M., Ikejima, T., & Nabeshima, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00295.x · Cited by 200
Brayne, C., the Cambridge City over-75s Cohort (CC75C) study neuropathology collaboration, Richardson, K., Matthews, F. E., Fleming, J., Hunter, S., Xuereb, J. H., Paykel, E., Mukaetova-Ladinska, E. B., Huppert, F. A., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1182 · Cited by 191
Hempen, B., & Brion, J.-P. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199609000-00003 · Cited by 175
Selley, M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00327-x · Cited by 174
Alzheimer disease pathology as a host response
Castellani, R. J., Lee, H.-G., Zhu, X., Perry, G., & Smith, M. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318177eaf4 · Cited by 171
Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD
Cottrell, D. A., Blakely, E. L., Johnson, M. A., Ince, P. G., & Turnbull, D. M. (2001) · Neurology · doi:10.1212/wnl.57.2.260 · Cited by 163
Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice
Quinn, J. F., Bussiere, J. R., Hammond, R. S., Montine, T. J., Henson, E., Jones, R. E., & Stackman, R. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.014 · Cited by 160
Prasanthi, J. R. P., Dasari, B., Marwarha, G., Larson, T., Chen, X., Geiger, J. D., & Ghribi, O. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.007 · Cited by 158
Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance.
Stocker, R. (1994) · PubMed · Cited by 151
Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease
Moreira, P. I., Siedlak, S. L., Wang, X., Santos, M. S., Oliveira, C. R., Tabaton, M., Nunomura, A., Szweda, L. I., Aliev, G., Smith, M. A., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240476.73532.b0 · Cited by 145
Self-citationCytochrome C Oxidase in Alzheimer's Disease Brain: Purification and Characterization
Parker, W. D., & Parks, J. K. (1995) · Neurology · doi:10.1212/wnl.45.3.482 · Cited by 142
Role of melatonin in Alzheimer-like neurodegeneration1
Wang, J., & Wang, Z. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00260.x · Cited by 138
Microglia and Alzheimer’s disease
Kalaria, R. N. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199901000-00004 · Cited by 135
Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease
Kontush, A., & Schekatolina, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.025 · Cited by 132
Stocker, R. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199412000-00005 · Cited by 129
Zheng, F., & Zhang, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.023 · Cited by 127
Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba
GALLUZZI, S. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.679a · Cited by 125
Mitochondrial failures in Alzheimer's disease
Zhu, X., Smith, M. A., Perry, G. L., & Aliev, G. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900611 · Cited by 125
Zhou, J., Zhang, S., Zhao, X., & Wei, T. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00570.x · Cited by 125
Quinn, J. F., Kulhanek, D. J., Nowlin, J., Jones, R. E., Praticò, D., Rokach, J., & Stackman, R. W. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.023 · Cited by 114
Economic considerations in the management of Alzheimer's disease
Zhu, C. W., & Sano, M. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.2.143 · Cited by 112
Coenzyme Q10 Treatment in Mitochondrial Encephalomyopathies
Lang, C. J. G., Sittl, H., & Erbguth, F. (2008) · European Neurology · doi:10.1159/000117445 · Cited by 106
Effects of $alpha;-tocopherol on an animal model of tauopathies
Nakashima, H., Ishihara, T., Yokota, O., Terada, S., Trojanowski, J. Q., Lee, V. M. ‐., & Kuroda, S. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.037 · Cited by 103
Metabolic Effects of Melatonin on Oxidative Stress and Diabetes Mellitus
Nishida, S. (2005) · Endocrine · doi:10.1385/endo:27:2:131 · Cited by 101
Upritchard, J. E., Schuurman, C. R. W. C., Wiersma, A., Tijburg, L. B. M., Coolen, S. A. J., Rijken, P. J., & Wiseman, S. A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.5.985 · Cited by 90
Botanical methods in ethnopharmacology and the need for conservation of medicinal plants
Hedberg, I. (1993) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(93)90006-q · Cited by 86
Mitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease
Dumont, M., Lin, M. T. S., & Beal, M. F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100507 · Cited by 85
Effects of melatonin on wortmannin-induced tau hyperphosphorylation
yan-qiu, D., Xu, G., Duan, P., Zhang, Q., & Wang, J. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00102.x · Cited by 81
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease
Siedlak, S. L., Casadesús, G., Webber, K. M., Pappolla, M. A., Atwood, C., Smith, M. A., & Perry, G. L. (2009) · Free Radical Research · doi:10.1080/10715760802644694 · Cited by 79
Wang, D., Ling, Z.-Q., Cao, F., Zhu, L., & Wang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00130.x · Cited by 79
Birkmayer, J. G. D. (1996) · PubMed · Cited by 77
Mechanisms and dynamics of antioxidant action of ubiquinol
Niki, E. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00035-6 · Cited by 77
Montiel, T., Quiroz‐Baez, R., Massieu, L., & Arias, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.126 · Cited by 72
Effect of melatonin on calyculin A-induced tau hyperphosphorylation
Li, X., Wang, X., Zhang, J., Wang, Q., & Wang, J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.023 · Cited by 68
Self-citationLi, Y. M., & Dickson, D. W. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00266-8 · Cited by 65
Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Mancuso, M., Orsucci, D., Siciliano, G., & Murri, L. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908946 · Cited by 63
Terada, A., Yoshida, M., Seko, Y., Kobayashi, T., Yoshida, K., Nakada, M., Nakada, K., Echizen, H., Ogata, H., & Rikihisa, T. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00119-7 · Cited by 61
Roth, M., Tomlinson, B. E., & Blessed, G. (1967) · PubMed · Cited by 59
Why Vitamin E Therapy Fails for Treatment of Alzheimer's Disease
Brewer, G. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1238 · Cited by 59
Brooks, W. S. (2003) · Brain · doi:10.1093/brain/awg084 · Cited by 59
Harrington, C. R., & Colaco, C. A. L. S. (1994) · Nature · doi:10.1038/370247a0 · Cited by 59
Positive effects of pollution?
Friebe, A., Malkewitz, J., Schultz, G., & Koesling, D. (1996) · Nature · doi:10.1038/382120a0 · Cited by 52
Free radical oxidative damage and Alzheimer's disease.
Tuppo, E. E., & FORMAN, L. J. (2001) · PubMed · Cited by 50
Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat.
Wang, X., Zhang, J., Yu, X., Liu, H., Zhou, Z., Zhang, Y., & Wang, J. (2005) · PubMed · Cited by 50
Self-citationVitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Pavlik, V., Doody, R. S., Rountree, S. D., & Darby, E. J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000255105 · Cited by 47
Bagi, Z. A., Csekõ, C., Tóth, E., & Koller, Á. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00448.2003 · Cited by 47
Growth hormone administration to aged animals reduces disulfide glutathione levels in hippocampus
Donahue, A., Aschner, M., Lash, L. H., Syversen, T. L. M., & Sonntag, W. E. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.003 · Cited by 45
Micronutrients and Alzheimer's disease
Staehelin, H. B. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2005459 · Cited by 44
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
García-Alloza, M., Borrelli, L. A., Hyman, B. T., & Bacskai, B. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.006 · Cited by 44
STRECK, E. L., Matté, C., Vieira, P. S., Calcagnotto, T., Wannmacher, C. M. D., Wajner, M., & Wyse, Â. T. D. S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00019-x · Cited by 41
Lü, C., Zhang, D., Whiteman, M., & Armstrong, J. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1865 · Cited by 40
Piwko, R. J., DeMello, R., Gramlich, R., Lasher, W., Osborn, D., Dombek, C., & Porter, K. (2007) · IEEE Power and Energy Magazine · doi:10.1109/mpe.2007.906307 · Cited by 30
González, C., Farias, G. A., & Maccioni, R. B. (1998) · PubMed · Cited by 30
Prabhakaram, M., & ORTWERTH, B. J. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1046 · Cited by 29
Oxidation of serum low-density lipoprotein (LDL) and antioxidant status in young and elderly humans
Nakamura, Y., Read, M., Elias, J. W., & Omaye, S. T. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2005.08.002 · Cited by 27
Autopsy-Confirmed Familial Early-Onset Alzheimer Disease Caused by the L153V Presenilin 1 Mutation
Janssen, J. C., Lantos, P. L., Fox, N. C., Harvey, R. J., Beck, J. A., Dickinson, A., Campbell, T. A., Collinge, J., Hanger, D. P., Cipolotti, L., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.6.953 · Cited by 26
Effects of vitamin B12 supplementation on choline acetyltransferase activity in cat brain.
Nadeau, A., & Roberge, A. G. (1988) · PubMed · Cited by 20
Aspects of Psychiatry in the Elderly
Roth, M., Tomlinson, B. E., & Blessed, G. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706000327 · Cited by 20
(2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000263876.99435.cb · Cited by 4
Cited by
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders
Enogieru, A. B., Haylett, W., Hiss, D. C., Bardien, S., & Ekpo, O. E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6241017 · Cited by 476
Metadata
- Authors
- Feng, Y., & Wang, X.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-17
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2141977412
- Cited by
- 379
- References
- 130
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.